7.4 (Q1)
CiteScore2024
Q2
Web of Science

GC-MS-Based Phytochemical Analysis, In-depth ADMET Screening and Molecular Docking Targeting EGFR for Anticancer Potential

Document Type : Original Article

Authors

1 Department of Pharmaceutical Chemistry, Malla Reddy Institute of Pharmaceutical Sciences, Malla Reddy Vishwavidyapeeth (Deemed to be University), Secunderabad, 500100, Telangana, India

2 Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai 600 117, India

3 Department of Analytical Research and Development, Cambrex, Charles City, Iowa- 50616, United States

4 Department of Regulatory Affairs, Hikma Pharmaceuticals USA Inc., 2 Esterbrook Lane, Cherry Hill, NJ 08003, United State

5 Department of Regulatory Affairs, Ricon Pharma LLC, 100 Ford Rd, Suite 9, Denville, NJ 07834, United State

6 Department of Regulatory Affairs, InvaGen Pharmaceuticals, A Cipla subsidiary, 550 South Research Place, Central Islip, NY 11722, United States

7 Department of Pharmacy Practice, Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad 244001, Uttar Pradesh, India

8 Cerevel Therapeutics 222 Jacobs St. Suite 200, Boston, Massachusetts 02141, United State

Abstract
Qurs-e-Ziabetus Khas is a classical unani herbal-mineral formulation traditionally prescribed for diabetes; however, its phytochemical composition and anticancer potential remain underexplored. This study aimed to standardize QZKH and elucidate its bioactive profile with a focus on epidermal growth factor receptor (EGFR) kinase–targeted activity. QZKH tablets were evaluated for organoleptic, physicochemical, and microbial parameters, followed by preliminary phytochemical screening, gas chromatography-mass spectrometry (GC–MS) based profiling, molecular docking against EGFR (PDB ID: 7SI1), and in silico ADMET analysis. Quality control studies confirmed acceptable pH (6.3–6.8), moisture, ash, and extractive values and the absence of foreign matter, heavy metals, pesticides, and pathogenic microbes, indicating a safe and standardized formulation. Phytochemical tests revealed carbohydrates, amino acids, fats and oils, cardiac and anthraquinone glycosides, saponins, alkaloids, phenolics, tannins, and flavonoids, supporting a strong antioxidant and metabolic regulatory potential. GC–MS analysis identified aromatic acids (benzeneacetic, hydrocinnamic), fatty acids (dodecanoic, tetradecanoic, oleic), cyclic dipeptides (cyclo (Pro–Ala), 3,6-diisopropylpiperazine-2,5-dione, phenylalanyl-leucine), long-chain amide (erucamide), and ursolic acid derivatives as key constituents. Docking studies showed that urs-12-en-23-oic acid, 3-(acetyloxy)-, methyl ester (–7.2 kcal/mol) and phenylalanyl-leucine (–5.8 kcal/mol) exhibited higher binding affinity to EGFR than the native ligand, stabilized by multiple hydrogen bonds and hydrophobic interactions. ADMET predictions highlighted cyclo (Pro–Ala), 3,6-diisopropylpiperazine-2,5-dione, hydrocinnamic acid, and benzeneacetic acid as drug-like, safe candidates with favorable pharmacokinetic and toxicity profiles. Collectively, these findings substantiate QZKH as a chemically rich, standardized formulation with promising EGFR-targeted anticancer potential, warranting further validation.

Graphical Abstract

GC-MS-Based Phytochemical Analysis, In-depth ADMET Screening and Molecular Docking Targeting EGFR for Anticancer Potential

Keywords

Subjects


OPEN ACCESS

©2026 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

MAJOR DATABASES, CITATION METRICS & CAPTURES

Google Scholar Scopus - SJR Web of Science PlumX Metrics |

[1] Ansari, A.P., Nasir, A. Therapeutic effect of ‘Qurs-i-Ziabetus Khas’ in diabetes mellitus–a case report. Journal of Ayurvedic and Herbal Medicine, 2020, 6(1), 4-8.
[2] Eqbal, K., Alam, M.A., Quamri, M.A., Sofi, G., Ahmad Bhat, M.D. Efficacy of Qurs-e-Gulnar in Ziabetus (type 2 Diabetes Mellitus): A single blind randomized controlled trial. Journal of Complementary and Integrative Medicine, 2021, 18(1), 147-153.
[3] Hamiduddin, M., Ali, W., Jahangeer, G., Al, A. Unani formulations for management of diabetes: An overview. International Journal of Green Pharmacy, 2018, 12(4), S769-783.
[4] Onguru, O., Scheithauer, B.W., Kovacs, K., Vidal, S., Jin, L., Zhang, S., Lloyd, R.V. Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas. Modern pathology, 2004, 17(7), 772-780.
[5] Bethune, G., Bethune, D., Ridgway, N., Xu, Z. Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update. Journal of Thoracic Disease, 2010, 2(1), 48.
[6] Wee, P., Wang, Z. Epidermal growth factor receptor cell proliferation signaling pathways. Cancers, 2017, 9(5), 52.
[7] Lisec, J., Schauer, N., Kopka, J., Willmitzer, L., Fernie, A.R. Gas chromatography mass spectrometry–based metabolite profiling in plants. Nature Protocols, 2006, 1(1), 387-396.
[9] Valdez, C.A. Gas chromatography-mass spectrometry analysis of synthetic opioids belonging to the fentanyl class: A review. Critical Reviews in Analytical Chemistry, 2022, 52(8), 1938-1968.
[10] Khan, S.L., Bakshi, V. LC-HRMS and in silico Analysis Of Ailanthus Excelsa Metabolites Targeting EGFR triple mutation (L858R/T790M/C797S), Advanced Journal of Chemistry, Section A. 2026, 9(2), 292-311.
[11] Gandla, K., Islam, F., Zehravi, M., Karunakaran, A., Sharma, I., Haque, M.A., Nainu, F. Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer. Heliyon, 2023, 9(9), 19454.
[12] Suryawanshi, R.M., Shimpi, R.B., Muralidharan, V., Nemade, L.S., Gurugubelli, S., Baig, S., Sweilam, S.H. Adme, toxicity, molecular docking, molecular dynamics, glucokinase activation, dpp‐iv, α‐amylase, and α‐glucosidase inhibition assays of mangiferin and friedelin for antidiabetic potential. Chemistry & Biodiversity, 2025, 22(5), e202402738.
[13] Sarraf, M., Sani, A.M., Atash, M.M.S. Physicochemical, organoleptic characteristics and image analysis of the doughnut enriched with oleaster flour. Journal of Food Processing and Preservation, 2017, 41(4), e13021.
[14] Pirzada, A.S., Khan, H., Alam, W., Darwish, H.W., Elhenawy, A.A., Kuznetsov, A., Daglia, M. Physicochemical properties, pharmacokinetic studies, DFT approach, and antioxidant activity of nitro and chloro indolinone derivatives. Frontiers in Chemistry, 2024, 12, 1360719.
[15] Siraj, M.B. Quality control and phytochemical validation of Saussurea lappa (Costus/Qust). International Journal of Green Pharmacy (IJGP), 2020, 14(1), 38–43.
[16] Sharma, M., Abid, R., Sajgotra, M. Phytochemical screening and thin layer chromatography of Ficus carica leaves extract. Pharmaceutical and Biosciences Journal, 2017, 18-23.
[17] Parvatikar, P.P., Madagi, S. Preliminary phytochemical analysis and biological screening of Indigofera hochestetteri. The Pharma Innovation Journal, 2018, 7(3):503–5.
[18] Ahmad, N., Shakil, A., Shinwari, Z.K., Ahmad, I., Wahab, A. Phytochemical study and antimicrobial activities of extracts and its derived fractions obtained from Berberis vulgaris L. and Stellaria media L. leaves. Pakistan Journal of Botany, 2022, 54(4), 1517-1521.
[19] Sevindik, M., Rasul, A., Hussain, G., Anwar, H., Zahoor, M.K., Sarfraz, I., Selamoglu, Z. Determination of anti-oxidative, anti-microbial activity and heavy metal contents of Leucoagaricus leucothites. Pakistan Journal of Pharmaceutical Sciences, 2018, 31(5 Supplement), 2163-2168.
[20] Sharma, P., Rathore, P., Choudhary, Y., Tatwade, Y., Joshi, A. Anti-microbial activity of seed oils & protein estimation of seed-content in Clitoria ternetea, Lagenaria siciraria & Ziziphus mauritiana. Brazilian Journal of Science, 2023, 2(8), 41-46.
[21] Nurani, L.H., Kumalasari, E., Zainab, Z., Mursyidi, A., Widyarini, S., Rohman, A. The determination of metal content, microbial contamination and dissolution assessment of the ethanol extract of pasak bumi root. Jurnal Pharmaciana, 2017, 7, 295-304.
[23] Rani, R., Sharma, D., Chaturvedi, M., Yadav, J.P. Phytochemical analysis, antibacterial and antioxidant activity of Calotropis procera and Calotropis gigantea. The Natural Products Journal, 2019, 9(1), 47-60.
[24] Ahmed, S., Tabassum, P., Falak, S., Ahmad, A., Shaikh, M. Molecular docking and network pharmacology: Investigating vitis vinifera phytoconstituents as multi-target therapeutic agents against breast cancer.   Journal of Pharmaceutical Sciences  and Computational Chemistry, 2025, 1(2), 116-134.
[25] Siddiqui, F., Makhloufi, R., Salah, M.E.-S., Mohamed, E., Hojjati, M. Computational exploration of quinine and mefloquine as potential anti-malarial agents. Journal of Pharmaceutical Sciences and Computational Chemistry, 2025, 1(2), 106-115.
[26] Tamboli, A., Tayade, S. In-depth investigation of berberine and tropane through computational screening as possible DPP-IV inhibitors for the treatment of T2DM. Journal of Pharmaceutical Sciences and Computational Chemistry, 2025, 1(1), 1-11.
[27] Khan, A., Unnisa, A., Sohel, M., Date, M., Panpaliya, N., Saboo, S.G., Khan, S. Investigation of phytoconstituents of enicostemma littorale as potential glucokinase activators through molecular docking for the treatment of type 2 diabetes mellitus. In Silico Pharmacology, 2021, 10(1), 1.
 
Volume 10, Issue 5
May 2026
Pages 465-488

  • Receive Date 04 December 2025
  • Revise Date 27 December 2025
  • Accept Date 20 January 2026